Hence, the present study demonstrated that Amblyomin-X promotes apoptotic morphological characteristics into tumor cells, accompanied by imbalance between the protein levels of Bcl-2 family members by decreasing anti-apoptotic and increasing pro-apoptotic levels, without p53 participation. This evidence concerns the gene TP53 and neoplasm.